NCT06866743

Brief Summary

The investigators are assessing how seasonal changes affect kidney function biomarkers in post-menopausal women, an understudied group. While heat stress can reduce kidney function, previous research has not accounted for physical activity, diet, hydration, or sun exposure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 3, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 14, 2025

Completed
24 days until next milestone

First Posted

Study publicly available on registry

March 10, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 3, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 3, 2025

Completed
Last Updated

October 6, 2025

Status Verified

September 1, 2025

Enrollment Period

8 months

First QC Date

February 14, 2025

Last Update Submit

September 30, 2025

Conditions

Keywords

Kidney HealthPost-MenopauseHeat StressHydrationOlder AdultsAgingPostmenopausal Women

Outcome Measures

Primary Outcomes (3)

  • Plasma neutrophil gelatinase-associated lipocalin (NGAL)

    Changes in NGAL will be measured in blood samples using enzyme-linked immunosorbent assay.

    Visit 1 (0 months) and Visit 2 (7 months)

  • Urinary neutrophil gelatinase-associated lipocalin (NGAL)

    Changes in NGAL will be measured in urine samples using radioimmunoassay.

    Visit 1 (0 months) and Visit 2 (7 months)

  • Insulin-like growth factor-binding protein 7 (IGFBP7)*Tissue inhibitor of metalloproteinase-2 (TIMP-2)

    The product of Insulin-like growth factor-binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinase-2 (TIMP-2) will be measured in blood samples using enzyme-linked immunosorbent assays.

    Visit 1 (0 months) and Visit 2 (7 months)

Secondary Outcomes (1)

  • estimated glomerular filtration rate (eGFR)

    Visit 1 (0 months) and Visit 2 (7 months)

Study Arms (2)

Winter

Assessment of the cohort in winter 2025 (visit 1).

Other: There will be no intervention.

Summer

Assessment of the cohort in summer 2025 (visit 2).

Other: There will be no intervention.

Interventions

This research focuses on examining seasonal variations in kidney function among postmenopausal females. As an observational study, our approach is non-interventional.

SummerWinter

Eligibility Criteria

Age55 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will be recruited from the greater Tallahassee, Florida area.

You may qualify if:

  • Female aged ≥55 years old
  • Self Reported as at least one year post-menopause
  • Live in Tallahassee, Florida, or the surrounding area

You may not qualify if:

  • Have a BMI of ≥30 kg/m2
  • Systolic blood pressure of ≥140 and/or diastolic blood pressure ≥90 mmHg
  • Self Reported Current or recent (regular use within the past six months) use of a diuretic medication
  • Self Reported: Uncontrolled cardiovascular, respiratory, neurological, renal, liver, or metabolic health condition
  • Current or recent (regular use within the past six months) use of tobacco, nicotine, nonsteroidal anti-inflammatory products
  • No regular (≥once per week) purposeful heat exposure (e.g., sauna, spa, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Florida State University

Tallahassee, Florida, 32306, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples and urine samples

MeSH Terms

Conditions

Heat Stress Disorders

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Officials

  • Joseph Watso, PhD

    Florida State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 14, 2025

First Posted

March 10, 2025

Study Start

January 3, 2025

Primary Completion

September 3, 2025

Study Completion

September 3, 2025

Last Updated

October 6, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

Data with all HIPAA identifiers removed may be shared in future collaborative efforts pending appropriate data and/or material transfer agreement approvals.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
One year after completion of the trial, indefinitely
Access Criteria
A formal plan identifying the intended use of the data and proper completion of appropriate data and/or material transfer agreement approvals with the study PI and their institution.

Locations